StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by bvg2328on Jan 07, 2018 7:04pm

212 Views

Post# 27302163

RE:The evolution of a liquid biopsy company.

Genenews has made big strides in 2017 and will realize some of their hard work in 2018. Mr Tripp is setting this company up to be a huge success!!. There might be a short time left to pennie flip and average down but don't get caught without shares when this starts it's run up. No imminent news is needed to move this stock in a hurry as has been seen before. Just my opinion Good luck everyone!

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario